SCHEMBL14539

SCHEMBL14539

CC(C)(C)OC(=O)/N=C(\N)NCCCCN1CCC(n2cc3c(nc2=O)[nH]c2ccccc23)C1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 1/20 0.36
DRD2 P14416 7/20 0.35
DRD3 P35462 4/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HSD17B10 Q99714 1/20 0.35
FAAH O00519 1/20 0.35
ACHE P22303 2/20 0.34
PLD2 O14939 1/20 0.34
PLD1 Q13393 1/20 0.34
CAMK2D Q13557 1/20 0.34
MAPK1 P28482 2/20 0.34
HTR1A P08908 1/20 0.34
HTR2A P28223 1/20 0.34
CCR2 P41597 1/20 0.34
CCR5 P51681 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14574 0.90 DRD2 (0.36) ADRA2CDRD2DRD3KDM4EALDH1A1
SCHEMBL14463 0.89 DRD2 (0.44) ADRA2CDRD2DRD3FAAHCAMK2D
SCHEMBL13698 0.83 DRD2 (0.37) DRD2DRD3KDM4EALDH1A1HSD17B10
SCHEMBL8076 0.83 DRD2 (0.37) DRD2DRD3KDM4EALDH1A1HSD17B10
SCHEMBL12061561 0.79 SLC6A4 (0.43) MEN1KMT2A
SCHEMBL17484485 0.79 SLC6A4 (0.43) MEN1KMT2A
SCHEMBL12062415 0.78 CHRM1 (0.48) DRD2KDM4EALDH1A1HSD17B10PLD1
SCHEMBL14077 0.75 SLC6A4 (0.47) DRD2DRD3HTR1AHTR2AMEN1
SCHEMBL14551 0.74 ADRA1D (0.52) DRD2DRD3ALDH1A1HTR1AHTR2A
SCHEMBL14035 0.72 SLC6A4 (0.39) KDM4EALDH1A1HSD17B10MAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011047319-A2 ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICALS, INC. (US) 2011-04-21 WO disclosed